MarketWise (MKTW) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
1 Dec, 2025Executive summary
Annual Meeting scheduled for June 12, 2025, to be held virtually, with voting on key proposals including director elections, an amendment to the 2021 Incentive Award Plan, and ratification of a new external auditor.
Record date for voting is April 17, 2025, with 2,647,468 Class A and 13,637,641 Class B shares outstanding, representing 16.3% and 83.7% of voting power, respectively.
A 1-for-20 reverse stock split was effected on April 2, 2025, with all share references post-split adjusted.
Board recommends voting FOR all proposals.
Voting matters and shareholder proposals
Election of two Class I Directors (Dr. David Eifrig and Van Simmons) to serve until the 2028 Annual Meeting.
Amendment to the 2021 Incentive Award Plan to increase the share reserve by 1,630,554 shares, extending the pool for grants through at least 2030.
Ratification of Grant Thornton LLP as the new independent registered public accounting firm for fiscal year 2025, replacing Deloitte & Touche LLP.
Board unanimously recommends voting FOR all proposals.
Board of directors and corporate governance
Board consists of seven directors divided into three staggered classes, with annual elections for expiring terms.
Four directors are considered independent under SEC and Nasdaq rules.
Board committees include Audit, Compensation, and Nominating and Corporate Governance, each with independent members and written charters.
Board leadership is currently separated between CEO and Chairman roles.
Directors may only be removed for cause by a majority vote of outstanding voting stock.
Latest events from MarketWise
- Q4 2025 billings surged 42% YoY, FY 2026 guidance raised, and dividends increased.MKTW
Q4 20256 Mar 2026 - Q4 2024 saw a return to billings growth, improved margins, and renewed strategic focus.MKTW
Emerging Growth Conference 7810 Jan 2026 - Vote on reverse stock split and share reduction to maintain Nasdaq listing and streamline capital structure.MKTW
Proxy Filing1 Dec 2025 - Vote to approve a 1-for-20 reverse stock split and reduce authorized shares for Nasdaq compliance.MKTW
Proxy Filing1 Dec 2025 - Key votes include director elections, incentive plan amendment, and auditor ratification.MKTW
Proxy Filing1 Dec 2025 - Q3 2025 net income was $17.9M on $81.3M revenue, with ARPU up 35.5% and a buyout proposal pending.MKTW
Q3 20256 Nov 2025 - Q2 2025 saw revenue and subscribers fall, but cash flow, billings, and capital returns strengthened.MKTW
Q2 20257 Aug 2025 - Net income rose to $22.7M in Q3 2024 despite sharp declines in revenue and subscribers.MKTW
Q3 202413 Jun 2025 - Net income surged to $21.2M in Q2 2024, while billings fell 40% amid Legacy Research wind-down.MKTW
Q2 202413 Jun 2025